Telix's Illuccix PSMA-PET Imaging Agent Approved in France
- Written by PR Newswire Asia - Asian Spectator
![]() |
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent
MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68...






